Trial Profile
Clinical Trials Insight: 700029331
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Intepirdine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 18 Dec 2007 New trial record.